The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TAS-102 versus placebo plus best supportive care in patients with metastatic colorectal cancer refractory to standard therapies: Final survival results of the phase III RECOURSE trial.
 
Robert J. Mayer
Honoraria - Amgen; AstraZeneca
 
Atsushi Ohtsu
Employment - Celgene (I)
Honoraria - Bayer Yakuhin
 
Takayuki Yoshino
Research Funding - Daiichi Sankyo; Lilly; Pfizer; Sumitomo Dainippon; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Alfredo Falcone
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Research Funding - Amgen (Inst); Bayer (Inst); Merck Serono (Inst); Roche (Inst); Sanofi (Inst)
 
Rocio Garcia-Carbonero
Honoraria - Amgen (I); Boehringer Ingelheim (I); Lilly (I); Merck (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Lilly (I); Pfizer (I); Roche (I)
Research Funding - IPSEN
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim (I); Ipsen; Lilly (I); Merck; Novartis; Pfizer; Pfizer (I); Roche; Roche (I); Sanofi
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Alberto F. Sobrero
Honoraria - Bayer; Celgene; Merck; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck; Pfizer
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Sanofi
 
Marc Peeters
No Relationships to Disclose
 
Fabio Benedetti
Employment - Taiho Pharmaceutical
Leadership - Taiho Pharmaceutical
 
Lukas Makris
Employment - Stathmi
Consulting or Advisory Role - Taiho Pharmaceutical
 
Hiroshi Ambe
Employment - Taiho Pharmaceutical
Stock and Other Ownership Interests - Otsuka
 
Alberto Zaniboni
No Relationships to Disclose
 
Yasuhiro Shimada
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Lilly (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst)
 
Kentaro Yamazaki
Speakers' Bureau - Taiho Pharmaceutical
 
Yoshito Komatsu
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Pharmaceutical (Inst)
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
Speakers' Bureau - Genomic Health
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Ben Tran
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Genentech (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)